Effects of esmolol on haemodynamic response to CO2 pneumoperitoneum for laparoscopic surgery

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 5, 1998, Pages 510-517

  Koivusalo, A M ^a   Scheinin, M ^b   Tikkanen, I ^c   Yli Suomu, T ^d   Ristkari, S ^d   Laakso, J ^e   Lindgren, L ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^e Mineral Laboratories   (Finland)

Author keywords

Carbon dioxide; Esmolol; Hemodynamics; Laparoscopy; Renal function

Indexed keywords

ADRENALIN; ALFENTANIL; ATRACURIUM; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE; ESMOLOL; GLYCOPYRRONIUM BROMIDE; HETASTARCH; ISOFLURANE; KETOPROFEN; MIDAZOLAM; N ACETYL BETA GLUCOSAMINIDASE; NORADRENALIN; OXYCODONE; PROPOFOL; RENIN; RINGER ACETATE; SODIUM CHLORIDE; VASOPRESSIN;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL RADIOGRAPHY; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ISCHEMIA; LAPAROSCOPIC SURGERY; MALE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINE VOLUME;

EID: 0031981546     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05159.x     Document Type: Article

References (38)

1. Odeberg S, Ljungqvist O, Svenberg T, Gannedahl B, Bäckdahl M, von Rosen A et al. Haemodynamic effects of pneumoperitoneum and the influence of posture during anaesthesia for laparoscopic surgery. Acta Anaesthesiol Scand 1994: 38: 276-283.
2. Lindgren L, Koivusalo A-M, Kellokumpu I. Conventional pneumoperitoneum compared with abdominal wall lift for laparoscopic cholecystectomy. Br J Anaesth 1995: 75: 567-572.
3. McDermott J, Regan M, Page R, Stokes M, Barry K, Moriarty D et al. Cardiorespiratory effects of laparoscopy with and without gas insufflation. Arch Surg 1995: 130: 984-988.
4. O'Leary E, Hubbard K, Tormey W, Cunningham J. Laparoscopic cholecystectomy: haemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position. Br J Anaesth 1996: 76: 640-644.
5. Wittgen C, Andrus C, Fitzgerald S, Baudendistel L, Dahms T, Kaminski D. Analysis of the hemodynamic and ventilatory effects of laparoscopic cholecystectomy. Arch Surg 1991: 126: 997-1001.
6. Mikami O, Kawakita S, Fujise K, Shingu K, Takahashi H, Matsuda T. Catecholamine release caused by carbon dioxide insufflation during laparoscopic surgery. J Urol 1996: 155: 1368-1371.
7. Charlson M, Mackenzie C, Gold J, Ales K, Topkins M, Fairlough G et al. The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery. Ann Surg 1989: 210: 637-648.
8. McLaughlin J, Scheeres D, Dean R, Bonnell B. The adverse hemodynamic effects of laparoscopic cholecystectomy. Surg Endosc 1995: 9: 121-124.
9. Feigh B, Berger D, Dougherty T, Dupuis J, Bartholomew H, Hickey R et al. Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy. Surgery 1994: 116: 733-741.
10. Kazama T, Ikeda K, Kato T, Kikura M. Carbon dioxide output in laparoscopic cholecystectomy. Br J Anaesth 1996: 76: 530-535.
11. Rasmussen J, Dauchot P, DePalma R, Sorensen B, Regula G, Anton A et al. Cardiac function and hypercarbia. Arch Surg 1978: 113: 1196-1200.
12. Price H. Effect of carbon dioxide on the cardiovascular system. Anesthesiology 1960: 21: 652-663.
13. Koivusalo A-M, Kellokumpu I, Lindgren L. Gasless cholecystectomy: comparison of postoperative recovery with conventional technique. Br J Anaesth 1996: 77: 567-580.
14. Fitzegerald S, Andrus C, Baudendistel L, Dahmst T, Kaminski D. Hypercarbia during carbon dioxide pneumoperitoneum. Am J Surg 1992: 163: 186-190.
15. McDougall E, Monk T, Wolf J, Hicks M, Clayman R, Gardner S et al. The effect of prolonged pneumoperitoneum on renal function in an animal model. J Am Coll Surg 1996: 182: 317-328.
16. Koivusalo A-M, Kellokumpu I, Scheinin M, Tikkanen I, Halme L, Lindgren L. Randomized comparison of the neuroendocrine response to laparoscopic cholecystectomy using either conventional or abdominal wall lift techniques. Br J Surg 1996: 83: 1532-1536.
17. Walder A, Aitkenhead A. Role of vasopressin in the haemodynamic response to laparoscopic cholecystectomy Br J Anaesth 1997: 78: 264-266.
18. Price R. Urinary enzymes, nephrotoxicity and renal disease. Toxicology 1982: 23: 99-134.
19. Fuhrman T, Ewell C, Pippin W, Weawer J. Comparison of the efficacy of esmolol and alfentanil to attenuate the hemodynamic response to emergence and extubation. J Clin Anesth 1992: 4: 444-447.
20. Vucevic M, Purdy G, Ellis F. Esmolol hydrochloride for management of the cardiovascular stress responses to laryngoscopy and tracheal intubation. Br J Anaesth 1992: 68: 529-530.
21. Gold M, Sachs D, Grossnoff D, Herrington C, Skillman C. Use of esmolol during anesthesia to treat tachycardia and hypertension. Anesth Analg 1989: 68: 101-104.
22. Miller D, Martineau R, Wynands J, Hill J. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: The Canadian multicentre trial. Can J Anaesth 1991: 38: 849-858.
23. Ornstein E, Young W, Ostapkovich N, Matteo R, Diaz J. Are all effects of esmolol equally rapid in onset. Anesth Analg 1995: 81: 297-300.
24. 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci 1991: 49: 75-84.
25. Fishman AP, Pietra GG. Handling of bioactive materials by the lung. N Engl J Med 1974: 291: 953-959.
26. Yakata M, Sugita O, Sakai T, Uchiyama K, Wada K. Urinary enzyme determination and its clinical significance. C. Enzyme derived from the kidney tubular epithelium N-acetyl-β-D-glucosaminidase. 4. Preclinical evaluation of the urinary NAG activity and changes in renal diseases. Rinsho Byori-Japanese Journal of Clinical Pathology. 1983: Spec No 56: 90-101.
27. Johansen J, Flaishon R, Sebel P. Esmolol reduces anesthetic requirements for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 1997: 86: 364-371.
28. Smith I, Hemelrijick J, White P. Efficacy of esmolol as a supplement to propofol-nitrous oxide anesthesia. Anesth Analg 1991: 73: 540-546.
29. Scheinin B, Scheinin M, Vuorinen J, Lindgren L. Alfentanil obtunds the cardiovascular responses to suxamethonium-facilitated laryngoscopy and intubation. Br J Anaesth 1989: 62: 385-392.
30. Ivankovich A, Miletich D, Albrecht R, Heyman H, Bonnet R. Cardiovascular effects of intraperitoneal insufflation with carbon dioxide and nitrous oxide in the dog. Anesthesiology 1975: 42: 281-287.
31. Cork R, Kramer T, Dreischmeier B, Behr S, DiNardo J. The effect of esmolol given during cardiopulmonary bypass. Anesth Analg 1995: 80: 28-40.
32. LeRoith D, Bark H, Nyska M, Click S. The effect of abdominal pressure on plasma antidiuretic hormone levels in the dog. J Surg Res 1982: 32: 65-69.
33. Cowley A, Liard J-F. Vasopressin and arterial pressure regulation. Hypotension 1988: 11: 25-36.
34. Miller M. Role of endogenous opioids in neurophysial function in man. J Clin Endocrinol Metab 1980: 50: 1016-1020.
35. Freeman R, Davis J. Factors controlling renin secretion and metabolism. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension. Physiology and Treatment. New York: McGraw Hill, 1983: 225-250.
36. Goldberg M, Torjman M, Bartkowski R, Mora C, Boerner T, Seltzer J. Time-course of respiratory depression after an alfentanil infusion-based anesthesia. Anesth Analg 1992: 75: 965-971.
37. White P. Clinical uses of intravenous anesthetic and analgesic infusions. Anesth Analg 1989: 68: 161-171.
38. Ghoneim M, Block R. Learning and consciousness during general anesthesia. Anesthesiology 1992: 76: 279-305.